Oruka Therapeutics, Inc. (ORKA) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of Oruka Therapeutics, Inc. and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ORKA
Oruka Therapeutics, Inc.
$80.32HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
SRRK
Scholar Rock Holding Corporation
$42.90HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — ORKA vs SRRK
growth of $100 · dividends reinvested · last 8yORKA +2.0% (+0.3%/yr)SRRK +180.0% (+13.7%/yr)SRRK compounded faster over this window
ORKA SRRK
ORKA vs SRRK: by the numbers
- •SRRK is the larger company ($5.14B vs $4.84B market cap).
Metrics side by side
Valuation
| Metric | ORKA | SRRK |
|---|---|---|
| P/B ratio | 4.36 | 20.26 |
Profitability
| Metric | ORKA | SRRK |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -11.92% | -161.00% |
| ROIC | -13.88% | -90.04% |
Growth (annualized)
| Metric | ORKA | SRRK |
|---|---|---|
| Total return CAGR (5Y) | 32.76% | 8.20% |
Frequently asked
- How have ORKA and SRRK total returns compared?
- Over the past 5 years, ORKA delivered 32.76% and SRRK delivered 8.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.